We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Use of Fetal Fibronectin to Predict Delivery Due to Abruptio Placenta

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01279369
Recruitment Status : Terminated (Study no longer feasible as quantitative assessment of fFN can only be performed at one laboratory.)
First Posted : January 19, 2011
Last Update Posted : January 12, 2015
Sponsor:
Information provided by (Responsible Party):

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : October 2012
  Study Completion Date : October 2012